Pathomorphology of the endocrine heart

  • G. Rippegather
Conference paper


Our present investigations show that the heart with its myoendocrine cells will probably become an important tool in the evaluation of the status of cardiovascular and renal diseases. Tissue of the endocrine heart, blood plasma, and urine from patients undergoing open heart surgery for aorto-coronary bypass and correction of valve and septum diseases was examined. The right auricular myoendocrine cells were studied with immunohistochemistry and electron microscopy for cardiac hormones (Cardiodilatin = CDD 99–126/alpha human ANP). Depending on the status of the patient, differing quantities of CDD-IR (Cardiodilatin immunoreactivity) in the myoendocrine cells were detected by light microscopy, which is confirmed by the granularity or, by autophagolytic processes as seen in the electron microscope. Furthermore, pre- and postoperative blood samples as well as 24 h urine samples were analyzed by radioimmunoassay to measure the concentrations of CDD 99–126/alpha hANP. The concentrations of CDD/ANP measured by radioimmunoassay in plasma and urine samples vary according to different heart diseases. The highest concentrations were obtained in patients with mitral valve diseases (plasma: 67.3 +/- 31.9 fmol/ml, urine: 138.1 +/- 42.6 fmol/ml and aorto-coronary bypass patients with hypertension (plasma: 50.1 +/- 18.5, urine: 93 +/- 25.9 fmol/ml). Similar conditions of plasma and urine samples were detected in normotensive ACB-patients (plasma: 27.7 +/- 9.3, urine: 48.9 +/- 13.7 fmol/ml) and patients with aortic stenosis (plasma: 15.7 +/- 5.9, urine: 43.7 +/- 21.7). Blood and urine samples were also examined by high pressure liquid chromatography (HPLC) to determine the molecular forms of their circulating CDD/hANP, which were then compared. The present work shows that pathomorphological analysis plays an important role in the diagnosis of cardiovascular diseases.

Since the discovery of the heart as an endocrine organ, its role in the regulation of blood pressure and electrolyte-water threshold (3,9) has become evident. In spite of numerous publications which show the importance of the endocrine heart (1,2,8) there is little information about ultrastructural changes of the atrial endocrine organ during various cardiovascular diseases. Thus, we studied the parameters available for diagnostic and prognostic tools in patients undergoing cardiac surgery, i.e., aorta-coronary bypass, valve replacement or repair, and interventions in cases of cardiac malformations.


Mitral Valve Aortic Stenosis Atrial Natriuretic Peptide High Pressure Liquid Chromatography Mitral Valve Stenosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cantin, M., Genest, J. (1985) The heart and the atrail natriuretic factor. Endocr Rev 6: 107–127PubMedCrossRefGoogle Scholar
  2. 2.
    Currie, M.G., Geller, D.M., Cole, B.R., Boylan, J.G., YuSheng, W., Holmberg, S.W., Needleman, P. (1983) Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria. Science 221: 71–73PubMedCrossRefGoogle Scholar
  3. 3.
    DeBold, A.J., Borenstein, H.B., Veress, A.T., Sonnenberg, H. (1981) A rapid and potent natriuretic response to intravenous injection of atrial extracts in rats. Life Sci 28: 89–94CrossRefGoogle Scholar
  4. 4.
    Dietz, R., Purgaj, J., Lang, R.E., Schoemig, A. (1986) Pressure dependent release of atrial natriuretic peptide (ANP) in patients with chronic cardiac disease: does it reset? Klin Wochenschr 64 (Suppl VI): 42–46PubMedGoogle Scholar
  5. 5.
    Forssmann, K., Hock, D., Herbst, F., Schulz-Kappe, P., Talartschik, J., Scheler, F., Forssmann, W.G. (1986) Isolation and structure of the circulating human cardiodilatin (alpha ANP). Klin Wochenschr 64: 1276–1280PubMedCrossRefGoogle Scholar
  6. 6.
    Forssmann, W.G., Pickel, V., Reinecke, M., Hock, D., Metz, J. (1981) Immunohisto-chemistry and immunocytochemistry of nervous tissue In: Heym, Ch., and Forssmann, W.G. (eds.), Techniques in neuroanatomical research. Springer, Berlin Heidelberg New York, pp 171–205CrossRefGoogle Scholar
  7. 7.
    Forssmann, W.G., Birr, C., Carlquist, M., Christmann, M., Finke, R., Henschen, A., Hock, D., Kirchheim, H., Kreye, V., Lottspeich, F., Metz, J., Mutt, V., Reinecke, M. (1984) The auricular myocardiocytes of the heart constitute an endocrine organ. Characterization of a porcine peptide hormone, cardiodilatin-126. Cell Tissue Res 238: 425–430PubMedCrossRefGoogle Scholar
  8. 8.
    Forssmann, W.G. (1986) Cardiac hormones. I. Review on the morphology, biochemistry, and molecular biology of the endocrine heart. Eur J Clin Invest 16: 439–451PubMedCrossRefGoogle Scholar
  9. 9.
    Lang, R.E., Thoelken, H., Ganten, D., Luft, P.C., Ruskoaho, H., Unger, Th. (1985) Atrial natriuretic factor — a circulating hormone stimulated by volume loading. Nature 314: 264–266PubMedCrossRefGoogle Scholar
  10. 10.
    Maldonado, C.A., Saggau, W., Forssmann, W.G. (1986) Cardiodilatin-immunoreactivity in specific atrial granules of human heart revealed by the immunogold stain. Anat Embryol 173: 295–298PubMedCrossRefGoogle Scholar
  11. 11.
    Marie, J.P., Guillemot, H. Hatt, P.Y. (1976) Le degrá de granulation des cardiocytes auriculaires. Études planimétrique au cours de différents apports d’eau et de sodium chez le rat. Path Biol 24: 549–554Google Scholar
  12. 12.
    Needlemann, P. (1986) Atriopeptin biochemical pharmacology. Fed Proc 45: 46–67Google Scholar
  13. 13.
    Rippegather, G., Maldonado, C.A., Schulz-Knappe, P., Hock, D., Lang, R.E., Forssmann, W.G. (1986) Morphologie der myoendokrinen Zellen des Rattenherzens bei akuten Veränderungen des Blutvolumens. Verh Anat Ges 81: 109–113Google Scholar
  14. 14.
    Rippegather, G., Saggau, W., Forssmann, W.G. (1987) Pathomorphologie des endokrinen Herzens In: Kreye, V.A.W., Bussmann, W.D. (Hrsg) ANP — Atriales natriuretisches Peptid und das kardiovaskuläre System. Steinkopff, Darmstadt, S 169–178Google Scholar
  15. 15.
    Sternberger, L.A. (1979) Cytochemistry. 2nd edn John Wiley and Sons, New YorkGoogle Scholar
  16. 16.
    Tanaka, H., Shindo, M., Gutkowska, J., Kinoshita, A., Urata, H., Ikeda, M., Arakawa, K. (1986) Effect of acute excercise on plasma immunoreactive atrial natriuretic factor. Life Sci 39: 1685–1693PubMedCrossRefGoogle Scholar
  17. 17.
    Yamanaka, M., Greenberg, B., Johnson, L., Seilhammer, J., Brewer, M., Friedman, T., Miller, J., Atlas, S., Laragh, J., Lewicki, J., Fiddes, J. (1984) Cloning and sequence analysis of the cDNA for the rat atrial natriureticfactor precursor. Nature 309: 719–722PubMedCrossRefGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt 1989

Authors and Affiliations

  • G. Rippegather
    • 1
  1. 1.Department of Anatomy and Cell BiologyUniversity of HeidelbergHeidelbergGermany

Personalised recommendations